吉林康乃尔药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
133
NMPA:133
Drug Approvals
Dexamethasone Sodium Phosphate Injection
- Product Name
- 地塞米松磷酸钠注射液
- Approval Number
- 国药准字H22020042
- Approval Date
- Nov 2, 2021
NMPA
Dexamethasone Sodium Phosphate Injection
- Product Name
- 地塞米松磷酸钠注射液
- Approval Number
- 国药准字H22020044
- Approval Date
- Nov 2, 2021
NMPA
Dexamethasone Sodium Phosphate Injection
- Product Name
- 地塞米松磷酸钠注射液
- Approval Number
- 国药准字H22020043
- Approval Date
- Nov 2, 2021
NMPA
Doxofylline and Glucose Injection
- Product Name
- 迈平希
- Approval Number
- 国药准字H20031017
- Approval Date
- Aug 31, 2021
NMPA
Lidocaine Hydrochloride Injection
- Product Name
- 盐酸利多卡因注射液
- Approval Number
- 国药准字H22020050
- Approval Date
- Aug 19, 2021
NMPA
Lidocaine Hydrochloride Injection
- Product Name
- 盐酸利多卡因注射液
- Approval Number
- 国药准字H22020051
- Approval Date
- Aug 19, 2021
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 14
- Next
Clinical Trials
No trials found
News
No news found